Drug Dosage Calculations
-
Subject Areas on Research
- A phase II trial of high dose carboplatin and paclitaxel with G-CSF and peripheral blood stem cell support followed by surgery and/or chest radiation in patients with stage III non-small cell lung cancer: CALGB 9531.
- Alemtuzumab for the prevention and treatment of graft-versus-host disease.
- Alternative calculations of individual patient time in therapeutic range while taking warfarin: results from the ROCKET AF trial.
- Antifungal Drugs in Newborns and Children.
- Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guideline.
- Appropriate chemotherapy dosing in obese patients with cancer.
- Automated bolus advisor control and usability study (ABACUS): does use of an insulin bolus advisor improve glycaemic control in patients failing multiple daily insulin injection (MDI) therapy? [NCT01460446].
- Beta-blocker and ACE-inhibitor dosing as a function of body surface area: From the HF-ACTION trial.
- Bleeding risk comparing targeted low-dose heparin with bivalirudin in patients undergoing percutaneous coronary intervention: results from a propensity score-matched analysis of the Evaluation of Drug-Eluting Stents and Ischemic Events (EVENT) registry.
- Body surface area and medication dosing in patients with heart failure with reduced ejection fraction.
- Budesonide nasal irrigations in the postoperative management of chronic rhinosinusitis.
- CYP2C19 pharmacogenetics versus standard of care dosing for selecting antiplatelet therapy in patients with coronary artery disease: A meta-analysis of randomized clinical trials.
- Cellular pharmacokinetic and pharmacodynamic analyses of ethacrynic acid: Implications in topical drug delivery in the eye.
- Chemotherapy dosing in overweight and obese patients with cancer.
- Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for codeine therapy in the context of cytochrome P450 2D6 (CYP2D6) genotype.
- Contemporary patterns of discharge aspirin dosing after acute myocardial infarction in the United States: results from the National Cardiovascular Data Registry (NCDR).
- Development of a Pediatric Physiologically-Based Pharmacokinetic Model of Clindamycin Using Opportunistic Pharmacokinetic Data.
- Dexmedetomidine Pharmacokinetics and a New Dosing Paradigm in Infants Supported With Cardiopulmonary Bypass.
- Dose of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers and Outcomes in Heart Failure: A Meta-Analysis.
- Dosing in neonates: special considerations in physiology and trial design.
- Drug Dosing and Pharmacokinetics in Children With Obesity: A Systematic Review.
- Early adoption of dabigatran and its dosing in US patients with atrial fibrillation: results from the outcomes registry for better informed treatment of atrial fibrillation.
- Effects of Ideal Versus Total Body Weight Dosage of Rabbit Antithymocyte Globulin on Outcomes of Kidney Transplant Patients With High Immunologic Risk.
- Efficacy and safety of alirocumab, a monoclonal antibody to PCSK9, in statin-intolerant patients: design and rationale of ODYSSEY ALTERNATIVE, a randomized phase 3 trial.
- First in human dose calculation of a single-chain bispecific antibody targeting glioma using the MABEL approach.
- Fluconazole dosing for the prevention or treatment of invasive candidiasis in young infants.
- Fludarabine-based conditioning for marrow transplantation from unrelated donors in severe aplastic anemia: early results of a cyclophosphamide dose deescalation study show life-threatening adverse events at predefined cyclophosphamide dose levels.
- Frequency and Outcomes of Reduced Dose Non-Vitamin K Antagonist Anticoagulants: Results From ORBIT-AF II (The Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II).
- Gaps in Drug Dosing for Obese Children: A Systematic Review of Commonly Prescribed Emergency Care Medications.
- Identifying optimal dosage regimes under safety constraints: An application to long term opioid treatment of chronic pain.
- Individualized low-density lipoprotein cholesterol reduction with alirocumab titration strategy in heterozygous familial hypercholesterolemia: Results from an open-label extension of the ODYSSEY LONG TERM trial.
- Ketoconazole and prednisone to prevent recurrent ischemic priapism.
- Lapatinib Plasma and Tumor Concentrations and Effects on HER Receptor Phosphorylation in Tumor.
- Obese Children Require Lower Doses of Pantoprazole Than Nonobese Peers to Achieve Equal Systemic Drug Exposures.
- Perceptions and experiences of using automated bolus advisors amongst people with type 1 diabetes: a longitudinal qualitative investigation.
- Performance of an Electronic Decision Support System as a Therapeutic Intervention During a Multicenter PICU Clinical Trial: Heart and Lung Failure-Pediatric Insulin Titration Trial (HALF-PINT).
- Pharmacokinetics of Clindamycin in Obese and Nonobese Children.
- Pharmacokinetics of the BCL-2 Inhibitor Venetoclax in Healthy Chinese Subjects.
- Pharmacokinetics of ticarcillin-clavulanate in premature infants.
- Population Analysis of Anidulafungin in Infants to Older Adults With Confirmed or Suspected Invasive Candidiasis.
- Population Pharmacokinetics of Durvalumab in Cancer Patients and Association With Longitudinal Biomarkers of Disease Status.
- Posaconazole's impact on prophylaxis and treatment of invasive fungal infections: an update.
- Prescribing for Children With Rheumatic Disease: Perceived Treatment Approaches Between Pediatric and Adult Rheumatologists.
- Profiling retrospective thyroid function data in complete thyroidectomy patients to investigate the HPT axis set point (PREDICT-IT).
- Rational opioid dosing in the elderly: dose and dosing interval when initiating opioid therapy.
- Regional Variations in Alirocumab Dosing Patterns in Patients with Heterozygous Familial Hypercholesterolemia During an Open-Label Extension Study.
- Reversing the new oral anticoagulants with prothrombin complex concentrates (PCCs): what is the evidence?
- Revisiting the Role of Aspirin for the Primary Prevention of Cardiovascular Disease.
- Safety and efficacy of adjusted-dose eptifibatide in patients with acute coronary syndromes and reduced renal function.
- Safety of warfarin dosing in the intensive care unit following the Fontan procedure.
- Safety, dosing, and pharmaceutical quality for studies that evaluate medicinal products (including biological products) in neonates.
- Short-Term Risk of Serious Fall Injuries in Older Adults Initiating and Intensifying Treatment With Antihypertensive Medication.
- Simulated Assessment of Pharmacokinetically Guided Dosing for Investigational Treatments of Pediatric Patients With Coronavirus Disease 2019.
- Tolerability of a new 10% liquid immunoglobulin for intravenous use, Privigen, at different infusion rates.
- Use of an automated bolus calculator reduces fear of hypoglycemia and improves confidence in dosage accuracy in patients with type 1 diabetes mellitus treated with multiple daily insulin injections.
- Use of automated bolus advisors may improve adherence to multiple daily insulin injection therapy.